MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,537,000 | +28.2% | 11,552 | -3.1% | 0.42% | -11.3% |
| Q3 2020 | $1,979,000 | +33.3% | 11,916 | +3.4% | 0.47% | +43.4% |
| Q4 2019 | $1,485,000 | +3.1% | 11,521 | -37.7% | 0.33% | -14.2% |
| Q3 2019 | $1,440,000 | -60.2% | 18,484 | -47.4% | 0.38% | -57.0% |
| Q2 2019 | $3,621,000 | +24.4% | 35,159 | -11.5% | 0.89% | +24.1% |
| Q1 2019 | $2,911,000 | -10.4% | 39,715 | -42.4% | 0.71% | +47.8% |
| Q3 2018 | $3,249,000 | -33.9% | 68,981 | -30.8% | 0.48% | -37.7% |
| Q2 2018 | $4,913,000 | +162.2% | 99,656 | +63.3% | 0.78% | +148.4% |
| Q1 2018 | $1,874,000 | +195.1% | 61,030 | +75.3% | 0.31% | +173.7% |
| Q4 2017 | $635,000 | -32.7% | 34,818 | +16.7% | 0.11% | -7.3% |
| Q4 2015 | $943,000 | +8.6% | 29,838 | +18.3% | 0.12% | -10.2% |
| Q3 2015 | $868,000 | -28.9% | 25,230 | -34.9% | 0.14% | -4.2% |
| Q2 2015 | $1,220,000 | – | 38,754 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |